Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04551885
Title FT516 in Combination With Monoclonal Antibodies in Advanced Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Fate Therapeutics

Advanced Solid Tumor


Cyclophosphamide + Fludarabine

Avelumab + FT516


Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Minnesota Masonic Cancer Center Minneapolis Minnesota 55455 United States Details
Hackensack University Medical Center/John Theurer Cancer Center Hackensack New Jersey 07601 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from for the field